Literature DB >> 20713247

Endolymphatic sac shunt, labyrinthectomy, and vestibular nerve section in Meniere's disease.

Karen B Teufert1, Joni Doherty.   

Abstract

Medical treatment for Meniere's disease is effective in controlling vertigo for approximately 85% of patients. However, when disabling vertigo continues, surgical therapy is indicated. Several surgical approaches are performed to control the symptoms of peripheral vestibular disorders refractory to medical measures, each procedure having many technical variations. Surgery is usually reserved for patients with disabling vertigo. Here, the authors discuss surgical options for vertigo control in Meniere's disease and review the literature on outcomes of these management options. The authors discuss endolymphatic sac shunt (ie, endolymphatic mastoid shunt), vestibular nerve section, cochleosacculotomy, and labyrinthectomy. When looking at data based on patient ratings, the authors find that surgery improves vertigo in endolymphatic sac shunt, vestibular nerve section, and labyrinthectomy groups and improves imbalance for the endolymphatic sac shunt and vestibular nerve section groups. Labyrinthectomy and translabyrinthine vestibular nerve section both offer excellent control of intractable vertigo. However, patients undergoing translab yrinthine vestibular nerve section are more likely to show improvement in imbalance and functional disability. This outcome is more likely for diagnoses other than Meniere's disease. There are potential prognostic factors that can be helpful in the preoperative or postoperative counseling of patients undergoing surgical treatment of vertigo. Patients who rate themselves as more disabled before surgery are less likely to achieve the best outcomes. Several other factors, such as duration of disease, contralateral tinnitus, eye disease, and allergy, may play a role. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20713247     DOI: 10.1016/j.otc.2010.05.014

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  8 in total

1.  Outcomes after cochlear implantation for patients with single-sided deafness, including those with recalcitrant Ménière's disease.

Authors:  Marlan R Hansen; Bruce J Gantz; Camille Dunn
Journal:  Otol Neurotol       Date:  2013-12       Impact factor: 2.311

2.  Menière's disease treated by grommet insertion.

Authors:  R G Kanegaonkar; A Najuko-Mafemera; R Hone; T Tikka
Journal:  Ann R Coll Surg Engl       Date:  2019-09-11       Impact factor: 1.891

Review 3.  Recent surgical options for vestibular vertigo.

Authors:  Stefan Volkenstein; Stefan Dazert
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

4.  Endolymphatic Sac Surgery for Ménière's Disease - Current Opinion and Literature Review.

Authors:  Maria de Lourdes Flores García; Carolina de la Llata Segura; Juan Carlos Cisneros Lesser; Carlo Pane Pianese
Journal:  Int Arch Otorhinolaryngol       Date:  2017-04

5.  Outcomes of Endolymphatic Sac Surgery for Meniere's Disease with and without Comorbid Migraine.

Authors:  Norman A Orabi; Brian M Kellermeyer; Christopher A Roberts; Stephen J Wetmore; Adam M Cassis
Journal:  Int J Otolaryngol       Date:  2021-12-24

6.  L-Thyroxine Improves Vestibular Compensation in a Rat Model of Acute Peripheral Vestibulopathy: Cellular and Behavioral Aspects.

Authors:  Guillaume Rastoldo; Emna Marouane; Nada El-Mahmoudi; David Péricat; Isabelle Watabe; Agnes Lapotre; Alain Tonetto; Alejandra López-Juárez; Abdessadek El-Ahmadi; Philippe Caron; Marie-José Esteve Fraysse; Christian Chabbert; Andreas Zwergal; Brahim Tighilet
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

7.  Comparison the results of two different vestibular system surgery in patients with persistent Meniere's disease.

Authors:  Saeed Soheilipour; Seyed Hamidreza Abtahi; Masoud Soltani; Hesam-Al-Din Khodadadi
Journal:  Adv Biomed Res       Date:  2015-09-28

8.  Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial).

Authors:  Christine Adrion; Carolin Simone Fischer; Judith Wagner; Robert Gürkov; Ulrich Mansmann; Michael Strupp
Journal:  BMJ       Date:  2016-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.